714
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Prevalence of Diabetic Retinopathy and Its Associated Factors among Diabetic Patients at Debre Markos Referral Hospital, Northwest Ethiopia, 2019: Hospital-Based Cross-Sectional Study

ORCID Icon, , ORCID Icon, & ORCID Icon
Pages 2179-2187 | Published online: 24 Jun 2020

References

  • Lee P, WHO members. Prevention of blindness from diabetes mellitus. World Health Organ. 2006:1–48.
  • Ghanchi F, Bailey C, Chakravarthy U, Cohen S, Dobson P, Gibson J. The royal college of ophthalmologists diabetic retinopathy guidelines. R Coll Ophthalmol. 2013;2:1–147.
  • Cook L, Kanski S. Clinical Ophthalmology. Vol. 8. ELSEVER; 2016:1–887.
  • Canada D, Practice C, Expert G. Retinopathy diabetes canada clinical practice guidelines expert committee. Can Diabetes Assoc. 2018;42:210–216.
  • Early Treatment Diabetic Retinopathy Study (ETDRS) Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs - an extension of the modified airlie house classification. ETDRS report number 10. Ophthalmology. 1991;98(5):786–806. doi:10.1016/S0161-6420(13)38012-9
  • Stry M, Health OF. Ministry of health guidelines for screening and management of diabetic retinopathy in Kenya. Minist Heal Kenya. 2017;4(2):1–64.
  • Wong TY, Sun J, Kawasaki R, et al. Guidelines on diabetic eye care: the international council of ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings. Ophthalmology. 2018;125(10):1608–1622. doi:10.1016/j.ophtha.2018.04.007
  • Hancho N, Kirigia J, Claude KO. IDF Diabetes Atlas. Vol. 8. International Diabetes Fedration; 2017:1–150.
  • Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis. 2015;2(1):1–25. doi:10.1186/s40662-015-0026-2.
  • Sabanayagam C, Riswana Banu D, Chee ML, et al. Incidence and progression of diabetic retinopathy: a systematic review. Lancet. 2018;7(2):140–149. doi:10.1016/S2213-8587(18)30128-1
  • Flaxman SR, Bourne RRA, Resnikoff S, et al. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(12):1221–1234. doi:10.1016/S2214-109X(17)30393-5
  • Shu D, Ting W, Ophth M, Chui G, Cheung M. Review diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol. 2016;44(4):260–277.
  • Lamoureux EL, Hassell JB, Keeffe JE. The impact of diabetic retinopathy on participation in daily living. Arch Ophthalmol. 2004;122(2):84–88. doi:10.1001/archopht.122.1.84
  • Chua J, Xin C, Lim Y, Wong TY. Diabetic retinopathy in the asia-pacific. Asia Pacific J Ophthalmol. 2018;7(1):3–16.
  • Gojka R, Cowan M. Global report on diabetes. World Health Organ. 2016;3:1–88.
  • Abebe N, Kebede T, Addise D. Review article diabetes in Ethiopia 2000–2016 – prevalence and related acute and chronic complications; a systematic review. African J Diabetes Med. 2017;25(2):7–12.
  • Heller M, Edelstein P, Mayer M. Membrane-bound enzymes. III. Protease activity in leucocytes in relation to erythrocyte membranes. BBA Biomembr. 1975;413(3):472–482. doi:10.1016/0005-2736(75)90130-3
  • Dell RB, Holleran S, Ramakrishnan R. NIH public access. Dell Al. 2012;43(4):207–213.
  • ADA. Standards of medical care in diabetes. Diabet Care. 2013;36(1):11–66. doi:10.2337/dc13-S011
  • American Academy of Pediatrics. Guideline # 4 Anthropometric Measurements. Vol. 8. 2016:1–7. Available from: [email protected].
  • Long J, Grasso J. Eye education for emergency clinicians eye. State Ophthalmol Serv. 2008;16(3):1–21.
  • Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3(1):1–8. doi:10.1186/1751-0473-3-17
  • Borges D, Mendanha DA, Martins M, Vilar C. Risk factors and incidence of diabetic retinopathy. Rev Bras Oftalmol. 2016;75(6):443–446.
  • Bharathi N, Kalpana S, Sujatha L, Nawab A, Kumar H. Prevalence of diabetic retinopathy in diabetics of rural population belonging to Ramanagara and Chikkaballapura districts of Karnataka. Int J Sci Res Publ. 2015;5(1):2250–3153.:.
  • Song P, Yu J, Chan KY, Theodoratou E, Rudan I. Prevalence, risk factors and burden of diabetic retinopathy in China: a systematic review and meta-analysis. J Glob Health. 2018;8(1). doi:10.7189/jogh.08.010803
  • Cui J, Ren JP, Chen DN, et al. Prevalence and associated factors of diabetic retinopathy in Beijing, China: a cross-sectional study. BMJ Open. 2017;7(8):1–6. doi:10.1136/bmjopen-2016-015473
  • Chisha Y, Terefe W, Assefa H, Lakew S, Reboldi G. Prevalence and factors associated with diabetic retinopathy among diabetic patients at Arbaminch General Hospital, Ethiopia: cross sectional study. PLoS One. 2017;12(3):1–9. doi:10.1371/journal.pone.0171987
  • Giloyan A, Harutyunyan T, Petrosyan V. The prevalence of and major risk factors associated with diabetic retinopathy in Gegharkunik province of Armenia: cross-sectional study. BMC Ophthalmol. 2015;15(46):1–7. doi:10.1186/s12886-015-0032-0
  • Okwanga PN, Mukona M, Mateveke K, Machingura PI, Macheka B, Gomo E. Prevalence and risk factors associated with retinopathy in diabetic patients at Parirenyatwa Hospital outpatients’ clinic in Harare, Zimbabwe. Arch Med Biomed Res. 2017;3(2):104. doi:10.4314/ambr.v3i2.6
  • Elwali ES, Almobarak AO, Hassan MA, Mahmooud AA, Awadalla H, Ahmed MH. Frequency of diabetic retinopathy and associated risk factors in Khartoum, Sudan: population based study. Int J Ophthalmol. 2017.
  • Sharew G, Ilako DR, Kimani KGY, Gelaw Y. Prevalence of diabetic retinopathy in Jimma University Hospital, Southwest Ethiopia. Ethiop Med J. 2013;51(2):105–113.
  • Ghaem H, Daneshi N, Riahi S, Dianatinasab M. The prevalence and risk factors for diabetic retinopathy in Shiraz, Southern Iran. Diabetes Metab J. 2018;42(6):538. doi:10.4093/dmj.2018.0047.
  • Adhikari BN, Gautam PS, Bekoju B, Basnet S, Bhandari H. Prevalence and associated risk factors for diabetic retinopathy among in-patients diagnosed with diabetes mellitus: a retrospective study conducted in nobel medical college and teaching hospital, Biratnagar. J Nobel Med Coll. 2018;7(1):50–55.
  • Rasoulinejad SA, Hajian-Tilaki K, Mehdipour E. Associated factors of diabetic retinopathy in patients that referred to teaching hospitals in Babol. Caspian J Intern Med. 2015;6(4):224–228.
  • Cleland CR, Burton MJ, Hall C, et al. Diabetic retinopathy in Tanzania: prevalence and risk factors at entry into a regional screening programme. Trop Med Int Health. 2016;21(3):417–426. doi:10.1111/tmi.12652
  • Ola MS, Nawaz MI. Cellular and molecular mechanism of diabetic retinopathy. INTECH Open. 2010;1:1–29.
  • Rask-madsen C, King GL. Review vascular complications of diabetes: mechanisms of injury and protective factors. CMET. 2012;17(1):20–33.
  • Cahalan MD, Nader N, Hodeify R, Kulkarni RPE-N-N. Effects of hyperglycemia on vascular smooth muscle Ca2+ signaling and oxidative stress. Biomed Res Int. 2017;(February):1–16.
  • Mathenge W, Bastawrous A, Peto T, et al. Prevalence and correlates of diabetic retinopathy in a population-based survey of older people in Nakuru, Kenya. Ophthalmic Epidemiol. 2014;21(3):169–177. doi:10.3109/09286586.2014.903982
  • Dabelea D, Stafford JM, Mayer-Davis EJ, et al. Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood. JAMA. 2017;317(8):825–835. doi:10.1001/jama.2017.0686
  • Kaštelan S, Tomić M, Gverović Antunica A, Ljubić S, Salopek Rabatić J, Karabatić M. Body mass index: a risk factor for retinopathy in type 2 diabetic patients. Mediators Inflamm. 2013;2013.
  • Ballard DJ, Melton LJ, Dwyer MS, et al. Risk factors for diabetic retinopathy: a population-based study in Rochester, Minnesota. Diabetes Care. 1986;9(4):334–342. doi:10.2337/diacare.9.4.334
  • Silha JV, Krsek M, Sucharda P, Murphy LJ. Angiogenic factors are elevated in overweight and obese individuals. Int J Obes. 2005;29(11):1308–1314. doi:10.1038/sj.ijo.0802987
  • Dorchy H, Claes C, Verougstraete C. Risk factors of developing proliferative retinopathy in type 1 diabetic patients: role of BMI. Diabetes Care. 2002;25(4):798–799. doi:10.2337/diacare.25.4.798
  • Rennie D. Trial registration: a great idea switches from ignored to irresistible. J Am Med Assoc. 2004;292(11):1359–1362. doi:10.1001/jama.292.11.1359